Cargando…

Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1

The majority of patients with lung cancer present with metastatic disease. Chronic inflammation and subsequent activation of NF-κB have been associated the development of cancers. The RelA/p65 subunit of NF-κB is typically associated with transcriptional activation. In this report we show that RelA/...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuan, Mayo, Marty W., Nagji, Alykhan S., Smith, Philip W., Ramsey, Catherine S., Li, Duo, Jones, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219802/
https://www.ncbi.nlm.nih.gov/pubmed/21765477
http://dx.doi.org/10.1038/onc.2011.308
_version_ 1782216899548938240
author Liu, Yuan
Mayo, Marty W.
Nagji, Alykhan S.
Smith, Philip W.
Ramsey, Catherine S.
Li, Duo
Jones, David R.
author_facet Liu, Yuan
Mayo, Marty W.
Nagji, Alykhan S.
Smith, Philip W.
Ramsey, Catherine S.
Li, Duo
Jones, David R.
author_sort Liu, Yuan
collection PubMed
description The majority of patients with lung cancer present with metastatic disease. Chronic inflammation and subsequent activation of NF-κB have been associated the development of cancers. The RelA/p65 subunit of NF-κB is typically associated with transcriptional activation. In this report we show that RelA/p65 can function as an active transcriptional repressor through enhanced methylation of the BRMS1 metastasis suppressor gene promoter via direct recruitment of DNMT-1 to chromatin in response to TNF. TNF-mediated phosphorylation of S276 on RelA/p65 is required for RelA/p65-DNMT-1 interactions, chromatin loading of DNMT-1, and subsequent BRMS1 promoter methylation and transcriptional repression. The ability of RelA/65 to function as an active transcriptional repressor is promoter specific as the NF-κB-regulated gene cIAP2 is transcriptionally activated while BRMS1 is repressed under identical conditions. Small molecule inhibition of either of the minimal interacting domains between RelA/p65-DNMT-1 and RelA/p65-BRMS1 promoter abrogates BRMS1 methylation and its transcriptional repression. The ability of RelA/p65 to directly recruit DNMT-1 to chromatin resulting in promoter-specific methylation and transcriptional repression of tumor metastasis suppressor gene BRMS1 highlights a new mechanism through which NF-κB can regulate metastatic disease, and offers a potential target for newer generation epigenetic oncopharmaceuticals.
format Online
Article
Text
id pubmed-3219802
institution National Center for Biotechnology Information
language English
publishDate 2011
record_format MEDLINE/PubMed
spelling pubmed-32198022012-09-01 Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1 Liu, Yuan Mayo, Marty W. Nagji, Alykhan S. Smith, Philip W. Ramsey, Catherine S. Li, Duo Jones, David R. Oncogene Article The majority of patients with lung cancer present with metastatic disease. Chronic inflammation and subsequent activation of NF-κB have been associated the development of cancers. The RelA/p65 subunit of NF-κB is typically associated with transcriptional activation. In this report we show that RelA/p65 can function as an active transcriptional repressor through enhanced methylation of the BRMS1 metastasis suppressor gene promoter via direct recruitment of DNMT-1 to chromatin in response to TNF. TNF-mediated phosphorylation of S276 on RelA/p65 is required for RelA/p65-DNMT-1 interactions, chromatin loading of DNMT-1, and subsequent BRMS1 promoter methylation and transcriptional repression. The ability of RelA/65 to function as an active transcriptional repressor is promoter specific as the NF-κB-regulated gene cIAP2 is transcriptionally activated while BRMS1 is repressed under identical conditions. Small molecule inhibition of either of the minimal interacting domains between RelA/p65-DNMT-1 and RelA/p65-BRMS1 promoter abrogates BRMS1 methylation and its transcriptional repression. The ability of RelA/p65 to directly recruit DNMT-1 to chromatin resulting in promoter-specific methylation and transcriptional repression of tumor metastasis suppressor gene BRMS1 highlights a new mechanism through which NF-κB can regulate metastatic disease, and offers a potential target for newer generation epigenetic oncopharmaceuticals. 2011-07-18 2012-03-01 /pmc/articles/PMC3219802/ /pubmed/21765477 http://dx.doi.org/10.1038/onc.2011.308 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Liu, Yuan
Mayo, Marty W.
Nagji, Alykhan S.
Smith, Philip W.
Ramsey, Catherine S.
Li, Duo
Jones, David R.
Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1
title Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1
title_full Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1
title_fullStr Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1
title_full_unstemmed Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1
title_short Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1
title_sort phosphorylation of rela/p65 promotes dnmt-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene brms1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219802/
https://www.ncbi.nlm.nih.gov/pubmed/21765477
http://dx.doi.org/10.1038/onc.2011.308
work_keys_str_mv AT liuyuan phosphorylationofrelap65promotesdnmt1recruitmenttochromatinandrepressestranscriptionofthetumormetastasissuppressorgenebrms1
AT mayomartyw phosphorylationofrelap65promotesdnmt1recruitmenttochromatinandrepressestranscriptionofthetumormetastasissuppressorgenebrms1
AT nagjialykhans phosphorylationofrelap65promotesdnmt1recruitmenttochromatinandrepressestranscriptionofthetumormetastasissuppressorgenebrms1
AT smithphilipw phosphorylationofrelap65promotesdnmt1recruitmenttochromatinandrepressestranscriptionofthetumormetastasissuppressorgenebrms1
AT ramseycatherines phosphorylationofrelap65promotesdnmt1recruitmenttochromatinandrepressestranscriptionofthetumormetastasissuppressorgenebrms1
AT liduo phosphorylationofrelap65promotesdnmt1recruitmenttochromatinandrepressestranscriptionofthetumormetastasissuppressorgenebrms1
AT jonesdavidr phosphorylationofrelap65promotesdnmt1recruitmenttochromatinandrepressestranscriptionofthetumormetastasissuppressorgenebrms1